Coadministration of 5% glucose solution has a decrease in bendamustine-related vascular pain grade

Abstract

Get full access to this article

View all access options for this article.

References

Ohmachi

Ando

Ogura

. Multicenter phaseII study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. Cancer Sci 2010; 101: 2059–2064.

Kahl

Bartlett

Leonard

. Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: Results from a multicenter study. Cancer 2010; 116: 106–114.

Prescribing Information from the PMDA about TREAKISYM® (bendamustine hydrochloride), http://www.info.pmda.go.jp/downfiles/ph/PDF/341209_4219405D1021_1_01.pdf (accessed 15 December 2011).

Prescribing Information from the FDA about TREANDA® (bendamustine hydrochloride), http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022249s005lbl.pdf (accessed 15 December 2011).

Brazeau

Cooper

Svetic

. Current perspectives on pain upon injection of drugs. J Pharm Sci 1998; 87: 667–677.